United States · FDA National Drug Code directory
Fingolimod
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43598-285_1d9a673c-7eb0-b5c3-eb90-9abce3ef9141
- Product NDC
- 43598-285
- Form
- CAPSULE
- Composition / generic term
- Fingolimod
- Labeler
- Dr. Reddy's Laboratories Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20221011
- Source listing expiry
- 20261231
Source-listed ingredients
- FINGOLIMOD HYDROCHLORIDE — .5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE in 1 BOTTLE (43598-285-30) · 43598-285-30
- 3 BLISTER PACK in 1 CARTON (43598-285-31) / 10 CAPSULE in 1 BLISTER PACK (43598-285-79) · 43598-285-31
- 1 BLISTER PACK in 1 CARTON (43598-285-70) / 7 CAPSULE in 1 BLISTER PACK · 43598-285-70
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →